AVADEL PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.3 USD | -0.16% |
|
+2.69% | +29.60% |
Chart calendar Avadel Pharmaceuticals plc
fb13c9268.SOap54BqHeqN60es-oqcKEwgA9AZN3kAMb9rWRmZzuo.cIPDitkfS4zqoHKYluHDfWFEeoZATUpxU-8zCyj_-Y4E1sqG9F1Y39uAfw~b6d91824693e1fe2cf78ef2b61f640c4
Upcoming events on Avadel Pharmaceuticals plc
Past events on Avadel Pharmaceuticals plc
| 08/04/2024 15:15 | Needham Healthcare Conference - Fireside Chat |
| 18/03/2024 16:30 | UBS Virtual CNS Day - Fireside Chat |
| 11/03/2024 19:20 | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 04/03/2024 12:30 | Q4 2023 Earnings Call |
| 04/03/2024 11:30 | Q4 2023 Earnings Release |
| 14/02/2024 19:00 | Oppenheimer Healthcare Life Sciences Conference |
| 29/11/2023 16:30 | Piper Sandler Healthcare Conference |
| 14/11/2023 17:00 | Jefferies London Healthcare Conference |
| 08/11/2023 13:30 | Q3 2023 Earnings Call |
| 08/11/2023 12:00 | Q3 2023 Earnings Release |
| 24/10/2023 22:00 | World Sleep Congress - Anne Marie Morse |
| 24/10/2023 22:00 | World Sleep Congress - Poster #103 |
| 24/10/2023 22:00 | World Sleep Congress - Poster Number :#106 |
| 24/10/2023 22:00 | World Sleep Congress - Poster Number :#096 |
| 24/10/2023 16:30 | World Sleep Congress - Evolving the Therapeutic Landscape for Narcolepsy |
| 23/10/2023 22:00 | World Sleep Congress - Poster Number :#109 |
| 23/10/2023 22:00 | World Sleep Congress - Poster #123 |
| 23/10/2023 22:00 | World Sleep Congress - Poster #119 |
| 23/10/2023 22:00 | World Sleep Congress - Poster Number :#120 |
| 23/10/2023 22:00 | World Sleep Congress - Poster #116 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 59,2 58,6 1.04% | 22,3 22,3 0.08% | 0,00 0,00 - | 0,00 0,00 - | 28,0 26,7 4.63% | 162 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -136 1,29 -10675.55% | 1,25 |
|
EBIT Million USD | Released Forecast Spread | -24,1 -20,7 -16.25% | 5,82 -6,54 188.96% | -85,5 -86,2 0.81% | -98,6 -89,1 -10.57% | -138 -138 0.3% | -32,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,6 -36,0 -7.03% | -5,08 -7,34 30.73% | -93,1 -91,9 -1.4% | -111 -101 -10.12% | -161 -159 -1.38% | -37,5 |
|
Net income Million USD | Released Forecast Spread | -33,2 -40,0 16.86% | 7,03 1,44 387.82% | -77,3 -79,0 2.17% | -137 -127 -8.58% | -160 -158 -1.75% | -32,6 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -0,07 |
| Announcement Date | 12/03/20 | 09/03/21 | 16/03/22 | 29/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,50 0,73 103.95% | 7,01 5,13 36.84% | 19,5 18,1 7.41% | 25,9 | 36,2 | 45,6 | 54,5 | 61,6 |
|
EBIT Million USD | Released Forecast Spread | -23,1 -23,8 2.83% | -28,6 -24,7 -15.85% | -26,3 -25,2 -4.62% | -17,0 -17,6 3.79% | -23,0 -14,5 -58.83% | -28,3 -22,8 -24.15% | -49,5 -29,0 -71.02% | -35,1 -32,5 -8.04% | -24,9 -25,3 1.66% | -21,1 | -12,0 | -3,46 | 3,80 | 6,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,6 -25,6 -4.18% | -30,7 -27,4 -12.26% | -33,3 -27,2 -22.37% | -20,1 -20,7 2.87% | -27,4 -17,3 -58.2% | -31,4 -25,5 -22.84% | -64,3 -31,5 -104.33% | -36,2 -33,4 -8.27% | -28,9 -26,7 -8.23% | -22,2 | -13,3 | -4,87 | 2,26 | 4,90 |
|
Net income Million USD | Released Forecast Spread | -22,3 -23,9 6.72% | -26,4 -25,4 -4.05% | -63,4 -23,6 -168.45% | -20,1 -15,2 -32.69% | -27,5 -16,5 -66.36% | -30,8 -25,7 -19.94% | -64,4 -31,4 -105.35% | -36,3 -33,3 -9.07% | -28,8 -26,0 -10.59% | -21,3 | -12,1 | -3,63 | 3,90 | 4,40 |
|
EPS USD | Released Forecast Spread | -0,01 | -0,01 | -0,02 | -0,03 | 0,52 | |||||||||
| Announcement Date | 16/03/22 | 09/05/22 | 09/08/22 | 09/11/22 | 29/03/23 | 04/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Avadel Pharmaceuticals plc
| Today 11:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| Today | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| Today | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 21:01 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 18:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 01/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVDL Stock
- Calendar Avadel Pharmaceuticals plc
